Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- MEDICAL DEVICE NEWS IN BRIEF
February 4, 2002
- Immediate PMS System Needs to Be Upgraded as It Is Operated
February 4, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
February 4, 2002
- 3 Companies Fail to Report Medical Device Malfunctions
February 4, 2002
- Kusuri Proverbs Reveal Japanese Spirit (2)
February 4, 2002
- REGULATORY NEWS IN BRIEF
February 4, 2002
- Nippon Kayaku: Drug Sales Up 2.7% but Profits Plummet
February 4, 2002
- Mr Nagayama Concerned about Downward Pressure After Price Revision
February 4, 2002
- Nichiiko: Branded Generic Business Boosts Sales, Profits
February 4, 2002
- Takeda Expects 2002 to Be Year of Implementation: President
February 4, 2002
- WORLD NEWS IN BRIEF
February 4, 2002
- Fukujin to Be Listed on TSE
February 4, 2002
- Elderly Patients Should Settle Accounts with Their Insurers
February 4, 2002
- Sanuki, Ohmori Yakuhin Shikoku, Baikado to Form Koyo on April 1
February 4, 2002
- Daiwa, Kowa to Tie Up in Shikoku
February 4, 2002
- Medical Fee Reduction to Seriously Hit Medical Institutions: JMARI
February 4, 2002
- Vital-Net, Ohmori Yakuhin Tohoku Postpone Merger
February 4, 2002
- BULLETIN
February 4, 2002
- Telmisartan to Be Copromoted by NBI, Yamanouchi
February 4, 2002
- Korosho's Preparations for NHI Price Revision Delay
February 4, 2002
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…